Potassium chloride supplementation diminishes platelet reactivity in humans.

Kimura Masayuki, et al.
Hypertension, 2004

Abstract

The prevalence of occlusive stroke is inversely correlated with potassium intake. We explored the hypothesis that a high potassium intake attenuates platelet reactivity, as expressed in ADP-evoked platelet aggregation. We studied healthy men (n=31) and women (n=42), blacks (n=33) and whites (n=40). In this cohort, we supplemented the habitual intake of 17 men and 21 women with 60 mmol KCl/70 kg body weight per day for 3 days and maintained 14 men and 21 women on their habitual intake. We then compared the change in ADP concentration causing 50% of the maximal initial rate (EC50) of platelet aggregation in the potassium-supplemented versus control groups. Potassium supplementation attenuated platelet reactivity, expressed by an increase in EC50 of platelet aggregation (P=0.0005), which was primarily attributable to an increase in EC50 in whites (P=0.0004). Urinary potassium excretion was significantly lower in blacks than in whites under basal conditions and after potassium supplementation. We conclude that potassium supplementation diminishes platelet reactivity, a phenomenon that provides a link between platelet biology and occlusive stroke.

PMID:15505115
Category:General properties of Potassium
Category:General properties of Potassium Chloride
Category:Minerals

The best supplements with Potassium or Potassium Chloride in Minerals category:

Articles similar to "Potassium chloride supplementation diminishes platelet reactivity in humans."

Previous article

Potassium citrate supplementation decreases the biochemical markers of bone loss in a group of osteopenic women: the results of a randomized, double-blind, placebo-controlled pilot study.

Next article

Effect of short-term supplementation of potassium chloride and potassium citrate on blood pressure in hypertensives.